Skip to main navigation Skip to search Skip to main content

Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

  • Niklas Klümper
  • , Damian J. Ralser
  • , Jörg Ellinger
  • , Florian Roghmann
  • , Julia Albrecht
  • , Eduard Below
  • , Abdullah Alajati
  • , Danijel Sikic
  • , Johannes Breyer
  • , Christian Bolenz
  • , Friedemann Zengerling
  • , Philipp Erben
  • , Kristina Schwamborn
  • , Ralph M. Wirtz
  • , Thomas Horn
  • , Dora Nagy
  • , Marieta Toma
  • , Glen Kristiansen
  • , Thomas Büttner
  • , Oliver Hahn
  • Viktor Grünwald, Christopher Darr, Eva Erne, Steffen Rausch, Jens Bedke, Katrin Schlack, Mahmoud Abbas, Stefanie Zschäbitz, Constantin Schwab, Alexander Mustea, Patrick Adam, Andreas Manseck, Bernd Wullich, Manuel Ritter, Arndt Hartmann, Jürgen Gschwend, Wilko Weichert, Franziska Erlmeier, Michael Hölzel, Markus Eckstein
  • University of Bonn and University Hospital Bonn
  • University Hospital Cologne
  • BRIDGE-Consortium Germany e.V.
  • Marien Hospital Herne
  • Universitätsklinikum Erlangen
  • BZKF)
  • University of Regensburg
  • University Medical Center Ulm and Center of Excellence 'Metabolic Disorders'
  • Universitätsmedizin Mannheim
  • Technical University of Munich
  • STRATIFYER Molecular Pathology GmbH
  • University Medical Center
  • University Hospital of Essen
  • University of Tübingen
  • Universitätsklinikum Münster
  • University Hospital Heidelberg
  • Heidelberg University
  • Ingolstadt Hospital
  • Klinikum Ingolstadt

Research output: Contribution to journalArticlepeer-review

180 Scopus citations

Fingerprint

Dive into the research topics of 'Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience